<DOC>
	<DOCNO>NCT00894608</DOCNO>
	<brief_summary>The purpose study determine whether letrozole combine gonadotropin effective ovarian hyperstimulating IVF/ICSI patient PCOS .</brief_summary>
	<brief_title>Letrozole Combined With Gonadotropins ( Gn ) Ovarian Stimulation Undergoing Vitro Fertilization/Intracytoplasmic Sperm Injection ( IVF/ICSI ) Patients With Polycystic Ovary Syndrome ( PCOS )</brief_title>
	<detailed_description>Polycystic ovarian syndrome ( PCOS ) occur 4 % 7 % woman reproductive age 20 % woman present anovulatory infertility . A significant proportion woman ultimately need assist reproductive technique . Various protocol ovarian stimulation step protocol , coast , GnRH antagonists et al propose optimize IVF result patient PCOS . The result study show satisfied . The preliminary study proven Letrozole , potent highly specific nonsteroidal aromatase inhibitor , could successfully induce ovulation woman polycystic ovary syndrome . In spite little study research letrozole IVF/ICSI cycle , poor ovarian responder , addition letrozole improve ovarian response FSH reduce gonadotrophin dose require COH without negative impact pregnancy rate . These report prompt u hypothesize adjunctive use letrozole COH protocol patient PCOS would minimize gonadotrophin dose , consequently cost , low risk OHSS IVF/ICSI treatment cycle .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>patient PCOS</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>letrozole</keyword>
	<keyword>ovarian stimulation</keyword>
	<keyword>PCOS</keyword>
	<keyword>IVF-ET</keyword>
</DOC>